DD123092A5 - - Google Patents
Info
- Publication number
- DD123092A5 DD123092A5 DD188433A DD18843375A DD123092A5 DD 123092 A5 DD123092 A5 DD 123092A5 DD 188433 A DD188433 A DD 188433A DD 18843375 A DD18843375 A DD 18843375A DD 123092 A5 DD123092 A5 DD 123092A5
- Authority
- DD
- German Democratic Republic
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US50702974A | 1974-09-18 | 1974-09-18 | |
| US05/594,918 US3980668A (en) | 1974-09-18 | 1975-07-10 | Anti-arrhythimic 5-endo-(3-indolecarbonyloxy)-N-[amino-(lower)alkyl]bicyclo[2,2,1]heptane-2,3-di-endo-carboxylic acid imides |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DD123092A5 true DD123092A5 (US07935154-20110503-C00006.png) | 1976-11-20 |
Family
ID=27055675
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DD188433A DD123092A5 (US07935154-20110503-C00006.png) | 1974-09-18 | 1975-09-18 |
Country Status (24)
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2557341A1 (de) * | 1975-12-19 | 1977-06-30 | Hoechst Ag | Basisch substituierte indolderivate und verfahren zu ihrer herstellung |
| US4139533A (en) * | 1976-08-19 | 1979-02-13 | Bristol-Myers Company | Bicyclo[2,2,1]heptane-2,3-diendo carboxylic acid imide esters of quinoline carboxylic acid |
| GB8814277D0 (en) * | 1988-06-16 | 1988-07-20 | Glaxo Group Ltd | Chemical compounds |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3850921A (en) * | 1972-09-20 | 1974-11-26 | I Matuo | Derivatives of 2,3-norbornanedicarboxamide |
-
1975
- 1975-07-10 US US05/594,918 patent/US3980668A/en not_active Expired - Lifetime
- 1975-09-04 YU YU2253/75A patent/YU40123B/xx unknown
- 1975-09-09 CA CA235,093A patent/CA1068281A/en not_active Expired
- 1975-09-12 IL IL48096A patent/IL48096A/xx unknown
- 1975-09-15 FI FI752572A patent/FI64352C/fi not_active IP Right Cessation
- 1975-09-15 NO NO753128A patent/NO144072C/no unknown
- 1975-09-16 SE SE7510362A patent/SE421421B/xx unknown
- 1975-09-16 IE IE2022/75A patent/IE42051B1/en unknown
- 1975-09-17 CS CS756301A patent/CS187489B2/cs unknown
- 1975-09-17 LU LU73418A patent/LU73418A1/xx unknown
- 1975-09-17 PL PL1975201921A patent/PL101454B1/pl unknown
- 1975-09-17 ES ES441038A patent/ES441038A1/es not_active Expired
- 1975-09-17 GB GB38221/75A patent/GB1484214A/en not_active Expired
- 1975-09-17 DK DK418075A patent/DK418075A/da not_active Application Discontinuation
- 1975-09-17 FR FR7528529A patent/FR2313047A1/fr active Granted
- 1975-09-17 DE DE19752541434 patent/DE2541434A1/de not_active Withdrawn
- 1975-09-17 PL PL1975183375A patent/PL100522B1/pl unknown
- 1975-09-17 PH PH17583A patent/PH11498A/en unknown
- 1975-09-17 NL NL7510934A patent/NL7510934A/xx not_active Application Discontinuation
- 1975-09-18 DD DD188433A patent/DD123092A5/xx unknown
- 1975-09-18 AT AT718575A patent/AT345275B/de active
- 1975-09-18 AR AR260435A patent/AR212235A1/es active
- 1975-09-18 HU HU75BI522A patent/HU173807B/hu unknown
- 1975-09-18 CH CH1210375A patent/CH615925A5/de not_active IP Right Cessation
- 1975-09-18 JP JP50112199A patent/JPS6039669B2/ja not_active Expired
-
1977
- 1977-02-15 ES ES455938A patent/ES455938A1/es not_active Expired
-
1982
- 1982-12-21 YU YU02840/82A patent/YU284082A/xx unknown
